Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema

European Journal of Pharmacology

Volumn 296, Issue 3, 1996, Pages 297-305

  Hirabayashi, Akiko ^a   Nishiwaki, Kimitoshi ^a   Shimada, Yasuhiro ^a   Ishikawa, Naohisa ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Aichi Prefectural Dietetic Association   (Japan)

Author keywords

Capillary permeability; Neuropeptide Y; Pulmonary edema; Sympathetic nervous system

Indexed keywords

CARBON; FIBRIN; FIBRINOGEN; MEPYRAMINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y3 RECEPTOR; NEUROPEPTIDE Y Y3 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [18-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NORADRENALIN; PAPAVERINE; PEPTIDE YY; PROPRANOLOL; PROTEIN; RECEPTOR SUBTYPE; THROMBIN; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; ISOLATED LUNG; LUNG EDEMA; LUNG PERFUSION; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0343586520     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00705-9     Document Type: Article

References (22)

1. 2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs, J. Appl. Physiol. 61, 2224.
2. Balasubramaniam, A. and S. Sheriff, 1990, Neuropeptide Y(18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventrić ular membranes, J. Biol. Chem. 265, 14724.
3. 1 receptor agonist, Proc. Natl. Acad. Sci. USA 87, 182.
4. Grundemar, L. and R. Håkanson, 1991, Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells, Br. J. Pharmacol. 104, 776.
5. Grundemar, L. and E.D. Högestätt, 1992, Unmasking the vasoconstrictor response to neuropeptide Y and its interaction with vasodilating agents in vitro, Eur. J. Pharmacol. 221, 71.
6. Hashiba, Y., N. Ishikawa, T. Sumita, K. Takagi, H. Hidaka and T. Satake, 1989, Capsaicin-sensitive nerves exert an inhibitory effect on the development of fibrin-induced pulmonary edema in rats, Am. Rev. Respir. Dis. 140, 652.
7. Hieble, J.P., J.G. Duesler, Jr. and R.N. Daly, 1989, Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation, J. Pharmacol. Exp. Ther. 250, 523.
8. Hirabayashi, A., K. Nishiwaki, K. Taki, Y. Shimada and N. Ishikawa, 1994, Effects of neuropeptide Y on lung vascular permeability in the pulmonary circulation of rats, Eur. J. Pharmacol. 256, 227.
9. Ishikawa, N., M. Kainuma, T. Furuta and Y. Sato, 1988, Factors influencing fibrin-induced pulmonary edema, Jpn. J. Pharmacol. 46, 255.
10. Kummer, W., A. Fischer, R. Kumkowski and C. Heym, 1992, The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry, Neuroscience 49, 715.
11. Lang, S.A., M.B. Maron, K.C. Maender and CF. Pilati, 1992, Circulatory neuropeptide Y does not produce pulmonary hypertension during massive sympathetic activation, J. Appl. Physiol. 73, 117.
12. Lundberg, J.M., L. Terenius, T. Hökfelt, C.R. Martling, K. Tatemoto, V. Mutt, J. Polak, S. Bloom and M. Goldstein, 1982, Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function, Acta Physiol. Scand. 116, 477.
13. Michel, M.C., 1991, Receptors for neuropeptide Y: multiple second messengers, Trends Pharmacol. Sci. 12, 389.
14. Michel, M.C., E. Schlicker, K. Fink, J.H. Boublik, M. Göthert, R.N. Willette, R.N. Daly, J.P. Hieble, J.E. River and H.J. Motulsky, 1990, Distribution of NPY-receptors in vitro and in vivo. I. NPY(18-36) discriminates NPY-receptor subtypes in vitro, Am. J. Physiol. 259, E131.
15. Minnear, F.L. and A.B. Malik, 1982, Mechanisms of neurogenic pulmonary edema, Ann. NY Acad. Sci. 384, 169.
16. Sakakibara, H., Y. Hashiba, K. Taki, M. Kawanishi, Y. Shimada and N. Ishikawa, 1992, Effect of sympathetic nerve stimulation on lung vascular permeability in the rat, Am. Rev. Respir. Dis. 145, 685.
17. Sheppard, M.N., J.M. Polak, J.M. Allen and S.R. Bloom, 1984, Neuropeptide tyrosine (NPY): a newly discovered peptide is present in the mammalian respiratory tract, Thorax 39, 326.
18. Van der Zee, H., A.B. Malik, B.C. Lee and T.S. Hakim, 1980, Lung fluid and protein exchange during intracranial hypertension and role of sympathetic mechanisms, J. Appl. Physiol. 48, 273.
19. Wahlestedt, C., L. Edvinsson, E. Ekblad and R. Håkanson, 1985, Neuropeptide Y potentiates norepinephrine-evoked vasoconstriction: mode of action, J. Pharmacol. Exp. Ther. 234, 735.
20. Wahlestedt, C., N. Yanaihara and R. Håkanson, 1986, Evidence for different pre- and post-junctional-receptors for neuropeptide Y and related peptides, Reg. Pept. 13, 307.
21. Wahlestedt, C., L. Edwinsson, E. Ekblad and R. Håkanson, 1987, Effect of neuropeptide Y at sympathetic neuroeffector junctions; existence of Yrand Y2-receptors, in: Neuronal Messengers in Vascular Function, eds. A. Nobin and C. Owman (Elsevier, Amsterdam) p. 231.
22. 3-type-receptors for neuropeptide Y/peptide YY, Life Sci. 50, PL7.